Design, synthesis and preliminary biological evaluation of rivastigmine-INDY hybrids as multitarget ligands against Alzheimer's disease by targeting butyrylcholinesterase and DYRK1A/CLK1 kinases
Article in RSC Medicinal Chemistry (March 2024)
The most recent citing publications are shown below. View all 395 publications that cite this research output on Dimensions.
Article in RSC Medicinal Chemistry (March 2024)
Article in Aging Medicine (December 2023)
Preprint in bioRxiv (June 2022)